-+ 0.00%
-+ 0.00%
-+ 0.00%

SAREPTA THERAPEUTICS PRESENTS NEW PRECLINICAL DATA DEMONSTRATING ROBUST KNOCKDOWN OF PATHOGENIC DMPK RNA IN THE NUCLEUS WITH SRP-1003 IN DM1 AT 2026 OLIGONUCLEOTIDE THERAPEUTICS SOCIETY ANNUAL MEETING

Reuters·10/14/2026 12:33:09